<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>9(2)</volume><submitter>Wang Z</submitter><funding>Construct Program of the Key Discipline in Hunan province</funding><pubmed_abstract>A series of 3',4',5'-trimethoxy flavonoids with benzimidazole linked by different chain alkanes have been designed and synthesized. The potential activity of these compounds as anti-tumor agents was evaluated by cytotoxicity assay in MGC-803 (human gastric cancer), MCF-7 (human breast cancer), HepG-2 (human hepatoma) and MFC (mouse gastric cancer) tumor cell lines. Among them, compound &lt;b>15&lt;/b> 7-(3-(2-chloro-1&lt;i>H&lt;/i>-benzo[&lt;i>d&lt;/i>]imidazol-1-yl)propoxy)-2-(3,4,5-trimethoxyphenyl)-4&lt;i>H&lt;/i>-chromen-4-one displayed the most potent antiproliferative activity, with IC&lt;sub>50&lt;/sub> values of 20.47 ± 2.07, 43.42 ± 3.56, 35.45 ± 2.03 μM and 23.47 ± 3.59 μM, respectively. The flow cytometry (FCM) results showed that compound &lt;b>15&lt;/b> caused the cell cycle to be arrested in G1 phase and induce</pubmed_abstract><journal>MedChemComm</journal><pagination>305-315</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6083785</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Design, synthesis and biological evaluation of 3',4',5'-trimethoxy flavonoid benzimidazole derivatives as potential anti-tumor agents.</pubmed_title><pmcid>PMC6083785</pmcid><pubmed_authors>Liu J</pubmed_authors><pubmed_authors>Zheng X</pubmed_authors><pubmed_authors>Cao X</pubmed_authors><pubmed_authors>Lei X</pubmed_authors><pubmed_authors>Xiong R</pubmed_authors><pubmed_authors>Xiong S</pubmed_authors><pubmed_authors>Chen Y</pubmed_authors><pubmed_authors>Tang G</pubmed_authors><pubmed_authors>Wang Z</pubmed_authors><pubmed_authors>Deng X</pubmed_authors></additional><is_claimable>false</is_claimable><name>Design, synthesis and biological evaluation of 3',4',5'-trimethoxy flavonoid benzimidazole derivatives as potential anti-tumor agents.</name><description>A series of 3',4',5'-trimethoxy flavonoids with benzimidazole linked by different chain alkanes have been designed and synthesized. The potential activity of these compounds as anti-tumor agents was evaluated by cytotoxicity assay in MGC-803 (human gastric cancer), MCF-7 (human breast cancer), HepG-2 (human hepatoma) and MFC (mouse gastric cancer) tumor cell lines. Among them, compound &lt;b>15&lt;/b> 7-(3-(2-chloro-1&lt;i>H&lt;/i>-benzo[&lt;i>d&lt;/i>]imidazol-1-yl)propoxy)-2-(3,4,5-trimethoxyphenyl)-4&lt;i>H&lt;/i>-chromen-4-one displayed the most potent antiproliferative activity, with IC&lt;sub>50&lt;/sub> values of 20.47 ± 2.07, 43.42 ± 3.56, 35.45 ± 2.03 μM and 23.47 ± 3.59 μM, respectively. The flow cytometry (FCM) results showed that compound &lt;b>15&lt;/b> caused the cell cycle to be arrested in G1 phase and induce</description><dates><release>2018-01-01T00:00:00Z</release><publication>2018 Feb</publication><modification>2025-04-04T09:45:58.721Z</modification><creation>2019-03-27T00:13:42Z</creation></dates><accession>S-EPMC6083785</accession><cross_references><pubmed>30108924</pubmed><doi>10.1039/c7md00578d</doi></cross_references></HashMap>